Meridian Bioscience, Inc. Reports Record Operating Results, Declares Regular Cash Dividend, Reaffirms Higher Fiscal 2007 Guidance, and Comments on Fiscal 2008 Outlook

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today: * reported record third quarter and nine-month sales of $29,763,000 and $90,577,000, respectively, an increase of 12% and 14% over the same periods of the prior fiscal year; * reported record third quarter and nine-month operating income of $9,473,000 and $26,350,000, respectively, an increase of 37% and 31% over the same periods of the prior fiscal year;